QNCX · Quince Therapeutics, Inc.
$32.86
+1.55 (+4.95%)
At close · Aug 27
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company concluded that substantial doubt about the Company's ability to continue as a going concern continues to exist within one year after the date these financial statements are available to be issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$31.84M
Shares
1.02M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-27 | 2026-08-23 | |
| DEF 14A | 2026-08-25 | 2026-10-06 | |
| 8-K | 2026-08-17 | — | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-14 | — | |
| 8-K | 2026-07-31 | 2026-07-29 | |
| 8-K/A | 2026-07-30 | 2026-05-17 | |
| 8-K | 2026-06-26 | — | |
| 8-K/A | 2026-06-26 | — | |
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-05-21 | 2026-05-20 | |
| 8-K/A | 2026-05-18 | 2026-05-17 | |
| 8-K | 2026-05-18 | 2026-05-17 | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-04-28 | 2026-04-27 | |
| DEF 14A | 2026-04-27 | 2026-06-11 | |
| 8-K | 2026-04-22 | — | |
| 10-K | 2026-04-10 | 2025-12-31 | |
| 8-K | 2026-04-09 | — | |
| 8-K | 2026-03-30 | 2026-03-27 | |
| 8-K | 2026-03-20 | 2026-03-16 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-02-02 | 2026-01-30 | |
| 8-K | 2026-01-29 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-10-17 | — | |
| 8-K | 2025-09-26 | 2025-09-25 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-07-16 | — | |
| 8-K | 2025-06-13 | 2025-06-12 | |
| 8-K | 2025-06-05 | 2025-06-04 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-23 | 2025-06-04 | |
| 8-K | 2025-03-24 | — | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2024-11-14 | 2024-11-12 | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-21 | 2024-06-20 | |
| 8-K | 2024-06-06 | 2024-06-05 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| DEF 14A | 2024-04-24 | 2024-06-05 | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-02-15 | 2024-02-13 | |
| 8-K | 2024-01-29 | 2024-01-23 |
Showing 1–50 of 112 filings
Key facts
CIK
1662774
CUSIP
22053A305
13F (30d)
32 filings
28 filers
Visit website
Investor relations